QDJ — Direct-To-Consumer Access Pharmacogenetic Assessment System Class II

FDA Device Classification

Classification Details

Product Code
QDJ
Device Class
Class II
Regulation Number
862.3364
Submission Type
Review Panel
CH
Medical Specialty
Medical Genetics
Implant
No

Definition

A direct-to-consumer access pharmacogenetic assessment system is a qualitative in vitro molecular diagnostic system used for detecting variants in nucleic acids isolated from human specimens the purpose of identifying pharmacogenetic associations for the detected variants. This device is for in vitro diagnostic use only, and is intended for direct access testing by lay users.